Gait and cognitive dysfunction in Parkinson's disease are partly related to an underlying cholinergic deficit. A randomized controlled trial that was recently published in Lancet Neurology investigated the effect of Rivastigmine, to ameliorate the cholinergic deficit, on gait variability in PD patients. The DynaPort Hybrid was used in this study to assess gait variability by means of the standard deviation of step times.

A paper by McRoberts’ founder and CEO Rob van Lummel on physical function in old age appeared in PLoS ONE this month. This paper demonstrates that, although physical performance (what you can do) and physical activity (what you actually do) are associated domains of physical function, older adults who do very well on physical performance tests are not per se more active.

McRoberts attended an exclusive three day PRO and eCOA Congress, which was held in Portugal. This congress is the industry’s foremost PRO & eCOAs event designed for attendees to gain expertise in the science, technologies, and regulatory requirements of patient reported outcomes (PROs) and electronic clinical outcome assessments (eCOA). The congress was hosted by ERT.

This year's European Respiratory Society Congress will be held in our homeland, The Netherlands. In Amsterdam we will present our new MoveMonitor analysis, that now also comprises a cycling detection and a stair climbing detection, all based on one sensor on the lower back! So, gaining insight in your patient's physical activity will be even more specific.

McRoberts will be present at the 4th International Conference on Ambulatory Monitoring of Physical Activity and Movement (ICAMPAM) in Limerick, Ireland from June 10-12, 2015.